Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $77.4400 (5.75%) ($74.0700 - $80.4500) on Mon. Apr. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.95% (three month average) | RSI | 49 | Latest Price | $77.4400(5.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(53%) XBI(52%) IWC(49%) IWM(48%) | Factors Impacting LGND price | LGND will decline at least -2.975% in a week (0% probabilities). VIXM(-26%) VXX(-16%) UUP(-16%) TLT(-3%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.975% (StdDev 5.95%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $72.72(6.49%) | 10 Day Moving Average | $71.92(7.68%) | 20 Day Moving Average | $75.42(2.68%) | To recent high | -28.2% | To recent low | 22.2% | Market Cap | $1.245b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |